Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM
Clinical trial NCT05199090 · TERMINATED
Trial details
- NCT number
- NCT05199090
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2023-05-11
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.